Related Experiment Video
Updated: Jul 1, 2025
08:56
Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
11.3K
Glial-restricted progenitor cells: a cure for diseased brain?
Piotr Rogujski1, Barbara Lukomska1, Miroslaw Janowski2
1NeuroRepair Department, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106, Warsaw, Poland.
Biological Research
|March 13, 2024
Summary
Glial-restricted progenitor cells (GRPs) are crucial for central nervous system (CNS) repair. This review explores GRPs
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Traditionally, glial cells were considered mere structural support in the central nervous system (CNS), unlike neurons.
- Emerging evidence highlights glia's critical role in neuronal maintenance and function, challenging the historical view.
- Glia replacement is a promising therapeutic strategy for CNS disorders, with glial progenitor cells being key.
Purpose of the Study:
- To review glial-restricted progenitor cells (GRPs), covering their origin, characteristics, and sources.
- To discuss the adaptation of GRPs in therapeutic approaches for various CNS diseases, especially myelin-related disorders.
- To present the clinical applications and future perspectives of GRP-based therapies for brain and spinal cord diseases.
Main Methods:
- Comprehensive literature review of GRPs, CNS diseases, and therapeutic strategies.
- Analysis of experimental therapies and clinical trials involving exogenous glia.
- Focus on myelin-related disorders and recent advancements in GRP research.
Main Results:
- GRPs are the source of new glial cells and hold significant therapeutic potential.
- Sophisticated experimental therapies and clinical trials demonstrate the utility of exogenous glia.
- GRPs are adaptable to therapeutic approaches for diverse CNS conditions, particularly myelin disorders.
Conclusions:
- Glial-restricted progenitor cells (GRPs) represent a powerful therapeutic avenue for CNS diseases.
- Further research and clinical trials are essential to fully realize the potential of GRP-based strategies.
- GRPs offer promising perspectives for treating debilitating brain and spinal cord conditions.
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
772
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
772
01:04Glial Cells
87.1K
Overview
87.1K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K